(Q36319430)

13 August 2017

1 reference

title

Seizure aggravation in idiopathic generalized epilepsies (English)

1 reference

13 August 2017

1 reference

Chaves J

1

1 reference

13 August 2017

Sander JW

series ordinal

2

1 reference

13 August 2017

publication date

1 January 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

46 Suppl 9

1 reference

13 August 2017

page(s)

133-139

1 reference

Idiopathic generalized epilepsy and choice of antiepileptic drugs.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Antiepileptic drugs as a cause of worsening seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

When antiepileptic drugs aggravate epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Chronic management of seizures in the syndromes of idiopathic generalized epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Current limitations of antiepileptic drug therapy: a conference review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Aggravation of partial seizures by antiepileptic drugs: is there evidence from clinical trials?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Anti-epileptic drugs-induced de novo absence seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Absence seizures and carbamazepine in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Exacerbation of epileptic seizures by carbamazepine: report of 10 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Spike-and-wave complexes and seizure exacerbation caused by carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Massive carbamazepine overdose: Clinical and pharmacologic observations in five episodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Status epilepticus after massive carbamazepine overdose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Carbamazepine may trigger new-onset epileptic seizures in an individual with autism spectrum disorders: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Long-term survival of people with unprovoked seizures: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Treatment considerations: traditional antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Phenobarbital-induced atypical absence seizure in benign childhood epilepsy with centrotemporal spikes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Absence seizures aggravated by valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Valproate-induced epileptic tonic status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Acute intoxication with sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Valproic acid therapy inducing absence status evolving into generalized seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Negative myoclonus during valproate-related stupor. Neurophysiological evidence of a cortical non-epileptic origin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Exacerbation generalized nonconvulsive seizures with ethosuximide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Non-convulsive status epilepticus associated with tiagabine therapy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Non-convulsive status epilepticus induced by tiagabine in a patient with pseudoseizure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Patients' versus caregivers' report of poor memory in relation to dementia and tested abilities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Myoclonic status epilepticus following high-dosage lamotrigine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Cataplexy and monoamine oxidase deficiency in Norrie disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Myoclonus in epilepsy patients with anticonvulsive add-on therapy with pregabalin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Paradoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Epileptic encephalopathies: a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Tiagabine-induced absence status in idiopathic generalized epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

Physiologic-pathologic correlation in Guillain-Barre syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00325.X

10.1111/J.1528-1167.2005.00325.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference